This inventor holds 3 USPTO granted patents and 2 EPO patents. Top assignees: Harvard College, Biochromix Ab. Active years: 2011-2022.
Location History:
- Linkoping, SE (2011 - 2022)
- Brookline, MA (US) (2022)
Company Filing History:
Years Active: 2011-2022
Title: Anna Herland: Innovator in Organ-on-a-Chip Technology
Introduction
Anna Herland is a prominent inventor based in Linkoping, Sweden. She has made significant contributions to the field of organ-on-a-chip technology, focusing on the development of devices that mimic human biological functions. With a total of 3 patents to her name, Herland's work is paving the way for advancements in biomedical research and drug testing.
Latest Patents
Herland's latest patents include an integrated multi-electrode array and trans-endothelial electrical resistance in organ-on-a-chip microsystems. This innovative device is designed for monitoring biological functions and features a membrane layer that acts as a barrier between two microchannels. The top layer of the device includes a plurality of transendothelial electrical resistance (TEER) measurement electrodes, allowing for direct monitoring of cell function and electrical activity. Additionally, the device incorporates a multi-electrode array (MEA) layer for similar monitoring of a second type of cells. Another notable patent involves the creation of a human blood-brain barrier (BBB) model derived from human pluripotent stem cells, which exhibits sustained TEER values over 2000 Ω·cm for at least three days after seeding.
Career Highlights
Throughout her career, Anna Herland has worked with prestigious institutions, including Harvard College and Biochromix AB. Her research has significantly impacted the field of tissue engineering and regenerative medicine. Her innovative approaches have garnered attention and respect within the scientific community.
Collaborations
Herland has collaborated with notable figures in her field, including Donald Elliot Ingber. These partnerships have further enhanced her research and contributed to the advancement of organ-on-a-chip technologies.
Conclusion
Anna Herland is a trailblazer in the field of organ-on-a-chip technology, with her patents and research contributing to significant advancements in biomedical applications. Her work continues to inspire future innovations in the industry.